Tudor E. Ciuleanu
Cluj-napoca, CJ, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer.
Journal: The New England journal of medicine
Published: July 22, 2026
Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 10, 2026
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, EGFR Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.
Journal: JTO clinical and research reports
Published: October 21, 2025
Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center.
Journal: Current issues in molecular biology
Published: August 15, 2025
Prospective Upfront Next-Generation Sequencing for Advanced Non-Small Cell Lung Cancer: Real-World Outcomes from the Ion Chiricuță Oncology Institute.
Journal: International journal of molecular sciences
Published: March 16, 2025
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study.
Journal: Therapeutic advances in medical oncology
Published: October 08, 2024
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity.
Journal: Medicine and pharmacy reports
Published: July 31, 2024
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 06, 2024
Next-generation sequencing as a valuable tool for mutational spectrum in advanced-stage NSCLC patients.
Journal: Medicine and pharmacy reports
Published: May 15, 2024
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective.
Journal: Cancers
Published: October 03, 2023
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 31, 2023
Last Updated: 09/26/2026